Currency In USD
| Previous Close | 5.34 |
| Open | 5.34 |
| Day High | 5.34 |
| Day Low | 5.34 |
| 52-Week High | 7.52 |
| 52-Week Low | 3 |
| Volume | 551,924 |
| Average Volume | 82,006 |
| Market Cap | 35.98M |
| PE | -0.57 |
| EPS | -9.37 |
| Moving Average 50 Days | 5.52 |
| Moving Average 200 Days | 5.11 |
| Change | 0 |
Data not available
XOMA Royalty Enters into Agreement to Acquire Generation Bio
GlobeNewswire Inc.
Dec 15, 2025 10:00 PM GMT
- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna - - Generation Bio’s cell-targeted lipid nanoparticles (ctLNP) delivery platform for small interfering RNA (siRNA) and
Generation Bio Announces Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 05, 2025 9:05 PM GMT
CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results Cash Position: Cash, cash equivalents, and marketab
Generation Bio Announces CEO Transition
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President CAMBRIDGE, MASS., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Generation